Agilon Health (AGL) Stock Price, News & Analysis

Company Overview

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.

Key Stats

• Today's Range: $2.26 to $2.43
• 50-Day Range: $2.10 to $4.49
• 52-Week Range: $1.50 to $7.73
• Volume: 3.94 million shs
• Average Volume: 4.80 million shs
• Market Capitalization: $989.34 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $4.79
• Consensus Rating: Hold

Agilon Health Stock Analysis - MarketRank™

Agilon Health scored higher than 43% of companies evaluated by MarketBeat, and ranked 672nd out of 936 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.1 / 5
• Analyst Rating: Hold

Consensus Rating

Agilon Health has received a consensus rating of Hold. The company's average rating score is 2.17, and is based on 5 buy ratings, 11 hold ratings, and 2 sell ratings.

Amount of Analyst Coverage

Agilon Health has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Agilon Health are expected to grow in the coming year, from ($0.59) to ($0.40) per share.

Price to Book Value per Share Ratio

Agilon Health has a P/B Ratio of 2.10. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

7.02% of the float of Agilon Health has been sold short.

Short Interest Ratio / Days to Cover

Agilon Health has a short interest ratio ("days to cover") of 4.1.

Change versus previous month

Short interest in Agilon Health has recently increased by 5.78%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Agilon Health does not currently pay a dividend.

Dividend Growth

Agilon Health does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

7.02% of the float of Agilon Health has been sold short.

Short Interest Ratio / Days to Cover

Agilon Health has a short interest ratio ("days to cover") of 4.1.

Change versus previous month

Short interest in Agilon Health has recently increased by 5.78%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 2.4 / 5
• News Sentiment: N/A

News Sentiment

Agilon Health has a news sentiment score of 0.40. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.88 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Agilon Health this week, compared to 5 articles on an average week.

Search Interest

4 people have searched for AGL on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days.

MarketBeat Follows

2 people have added Agilon Health to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Agilon Health insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 3.57% of the stock of Agilon Health is held by insiders.

AGL Stock Analysis - Frequently Asked Questions

How have AGL shares performed this year?

Agilon Health's stock was trading at $1.90 at the beginning of the year. Since then, AGL shares have increased by 25.8% and is now trading at $2.39.
View the best growth stocks for 2025 here.

How were Agilon Health's earnings last quarter?

Agilon Health, Inc. (NYSE:AGL) announced its quarterly earnings data on Tuesday, May, 6th. The company reported $0.03 EPS for the quarter, topping analysts' consensus estimates of ($0.01) by $0.04. The company's revenue was down 4.5% on a year-over-year basis.
Read the conference call transcript.

When did Agilon Health IPO?

Agilon Health (AGL) raised $1 billion in an initial public offering on Thursday, April 15th 2021. The company issued 46,600,000 shares at a price of $20.00-$23.00 per share. J.P. Morgan, Goldman Sachs, BofA Securities, Deutsche Bank Securities and Wells Fargo Securities served as the underwriters for the IPO and William Blair, Truist Securities and Nomura were co-managers.

How do I buy shares of Agilon Health?

Shares of AGL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Agilon Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Agilon Health investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), The RMR Group (RMR), AU Optronics (AUOTY), DiamondRock Hospitality (DRH) and Voyager Therapeutics (VYGR).

Company Calendar

• Last Earnings: 5/06/2025
• Today: 7/01/2025
• Next Earnings (Estimated): 8/05/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Medical Services
• Sub-Industry: Healthcare
• Current Symbol: NYSE:AGL
• CIK: 1831097
• Web: agilonhealth.com
• Phone: 562-256-3800
• Fax: N/A
• Employees: 1,076
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $4.79
• High Stock Price Target: $9.00
• Low Stock Price Target: $3.00
• Potential Upside/Downside: +100.2%
• Consensus Rating: Hold
• Rating Score (0-4): 2.17
• Research Coverage: 18 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.59)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$260.15 million
• Net Margins: -4.04%
• Pretax Margin: -4.24%
• Return on Equity: -45.47%
• Return on Assets: -12.76%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.20
• Quick Ratio: 1.20

Sales & Book Value

• Annual Sales: $6.06 billion
• Price / Sales: 0.16
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $1.14 per share
• Price / Book: 2.10

Miscellaneous

• Outstanding Shares: 413,950,000
• Free Float: 399,174,000
• Market Cap: $989.34 million
• Optionable: Not Optionable
• Beta: 0.16